AMA CPT® Assistant - 2022 Issue 7 (July)
Molecular Fluorescent Imaging of Skin (July 2022)
July 2022 page 12 Molecular Fluorescent Imaging of Skin For the Current Procedural Terminology (CPT ® ) 2022 code set, two new Category III codes ( 0700T , 0701T ) were added to describe molecular fluorescent imaging of nevus or nevi that are clinically suspicious of potential significant atypia or malignant melanoma. This process is used to identify biological activity that could potentially develop into melanoma. The new codes are used to report the first lesion ( 0700T ) and each additional lesion ( 0701T ). Category III Codes 0700T Molecular fluorescent imaging of suspicious nevus; first lesion ...
Subscribe or sign in to view the full article.
Article Overview
This article explains a July 2022 CPT Assistant update focused on molecular fluorescent imaging of skin lesions and the addition of new Category III codes in the CPT 2022 code set. It is aimed at coders, billers, and clinicians who need to understand the scope of the new reporting options, the type of clinical scenarios they apply to, and the accompanying procedural examples and descriptions presented in the article.
Why This Topic Matters
It helps readers identify whether the CPT 2022 changes affect imaging-related documentation and reporting for suspicious skin lesions, especially when evaluating article relevance for coding workflows and education.
Article Sections
-
Molecular Fluorescent Imaging of Skin
Overview of the CPT 2022 update and the imaging topic covered in the article. Introduces the general clinical context for the new reporting guidance.
-
Category III Codes
Summary of the new CPT Category III additions discussed in the article. Covers the general reporting framework and related examples included in the update.
-
Clinical Example and Description of Procedure
Clinical scenario and procedural narrative for the first of the new imaging codes. Provides a typical use case and the associated workflow description at a high level.
-
Clinical Example and Description of Procedure
Clinical scenario and procedural narrative for the additional-lesion imaging code. Describes the type of follow-up reporting context presented in the article.
What You Will Learn
- The scope of the CPT 2022 update for molecular fluorescent imaging of skin lesions
- How the article frames the clinical context for suspicious nevi and related imaging
- What kinds of examples and procedural narratives are included in the update
- How the article distinguishes the first lesion from additional-lesion reporting at a general level
Who Should Read This
- Medical coders
- Coding educators
- Dermatology practices
- Clinical documentation staff
- Billing professionals
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com